Filed: 5/15/2025ACC: 0001964437-25-000005
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 21 equity positions with a total reported market value of $198.16M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$198.16M
Total AUM (reported)
12.49M
Total Shares
Allocation by class
COM$127.19M64.2%
SPONSORED ADR$39.26M19.8%
CLASS A ORD$13.43M6.8%
SPONSORED ADS$9.91M5.0%
CL A$3.92M2.0%
ORDINARY SHARES$2.38M1.2%
ADS$2.07M1.0%
Portfolio Concentration
Top 3$70.93M35.8%
4–10$82.40M41.6%
11–25$44.83M22.6%
Top 3 weight
35.8%
Top 10 weight
77.4%
Voting Authority Distribution
Total shares with voting rights: 12.49M
Sole
Full voting authority
12.49M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings21
Rows:
ASCENDIS PHARMA A/S
SOLEShares199.26K
TypeSH
Market value$31.06M
15.67%
Sole
199.26K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares518.18K
TypeSH
Market value$25.72M
12.98%
Sole
518.18K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares577.70K
TypeSH
Market value$14.15M
7.14%
Sole
577.70K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares413.71K
TypeSH
Market value$13.88M
7.00%
Sole
413.71K
Shared
0.00
None
0.00
MERUS N V
SOLEShares323.21K
TypeSH
Market value$13.60M
6.87%
Sole
323.21K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares343.85K
TypeSH
Market value$13.43M
6.78%
Sole
343.85K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.04M
TypeSH
Market value$12.79M
6.46%
Sole
1.04M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares1.09M
TypeSH
Market value$11.06M
5.58%
Sole
1.09M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.48M
TypeSH
Market value$8.87M
4.47%
Sole
1.48M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares232.29K
TypeSH
Market value$8.77M
4.43%
Sole
232.29K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares2.43M
TypeSH
Market value$8.59M
4.33%
Sole
2.43M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares13.86K
TypeSH
Market value$8.20M
4.14%
Sole
13.86K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares448.69K
TypeSH
Market value$6.45M
3.26%
Sole
448.69K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares598.19K
TypeSH
Market value$4.38M
2.21%
Sole
598.19K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares560.98K
TypeSH
Market value$3.92M
1.98%
Sole
560.98K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares552.93K
TypeSH
Market value$3.46M
1.74%
Sole
552.93K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares255.06K
TypeSH
Market value$2.94M
1.49%
Sole
255.06K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares116.35K
TypeSH
Market value$2.38M
1.20%
Sole
116.35K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares732.46K
TypeSH
Market value$2.07M
1.04%
Sole
732.46K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares59.02K
TypeSH
Market value$1.98M
1.00%
Sole
59.02K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares499.25K
TypeSH
Market value$454.3K
0.23%
Sole
499.25K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 199.26K | SH | $31.06M 15.67% | 199.26K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 518.18K | SH | $25.72M 12.98% | 518.18K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 577.70K | SH | $14.15M 7.14% | 577.70K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 413.71K | SH | $13.88M 7.00% | 413.71K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 323.21K | SH | $13.60M 6.87% | 323.21K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 343.85K | SH | $13.43M 6.78% | 343.85K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.04M | SH | $12.79M 6.46% | 1.04M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 1.09M | SH | $11.06M 5.58% | 1.09M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.48M | SH | $8.87M 4.47% | 1.48M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 232.29K | SH | $8.77M 4.43% | 232.29K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 2.43M | SH | $8.59M 4.33% | 2.43M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 13.86K | SH | $8.20M 4.14% | 13.86K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 448.69K | SH | $6.45M 3.26% | 448.69K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 598.19K | SH | $4.38M 2.21% | 598.19K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 560.98K | SH | $3.92M 1.98% | 560.98K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 552.93K | SH | $3.46M 1.74% | 552.93K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 255.06K | SH | $2.94M 1.49% | 255.06K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 116.35K | SH | $2.38M 1.20% | 116.35K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 732.46K | SH | $2.07M 1.04% | 732.46K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 59.02K | SH | $1.98M 1.00% | 59.02K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 499.25K | SH | $454.3K 0.23% | 499.25K | 0.00 | 0.00 |